Search by Drug Name or NDC
NDC 25021-0114-66 Ciprofloxacin 2 mg/mL Details
Ciprofloxacin 2 mg/mL
Ciprofloxacin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is CIPROFLOXACIN.
MedlinePlus Drug Summary
Ciprofloxacin injection is used to treat certain infections caused by bacteria such as pneumonia; and infections of the skin, bone, joint, abdomen (stomach area), urinary tract, and prostate (male reproductive gland). Ciprofloxacin injection is also used to treat patients who have fever and are at high risk for infection because they have very few white blood cells. Ciprofloxacin injection is also used to prevent or treat plague (a serious infection that may be spread on purpose as part of a bioterror attack) and inhalation anthrax (a serious infection that may be spread by anthrax germs in the air on purpose as part of a bioterror attack). Ciprofloxacin may also be used to treat bronchitis and sinus infections, but should not be used for these conditions if there are other treatment options available. Ciprofloxacin injection is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. Antibiotics such as ciprofloxacin injection will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 25021-0114-66Last Updated: 02/05/2023
MedLinePlus Full Drug Details: Ciprofloxacin Injection
Product Information
NDC | 25021-0114 |
---|---|
Product ID | 25021-114_c30953aa-a1e5-45b5-97a5-6bb9d0b0bd6f |
Associated GPIs | 05000020112024 05000020112028 |
GCN Sequence Number | 015920 |
GCN Sequence Number Description | ciprofloxacin in 5 % dextrose PIGGYBACK 200MG/0.1L INTRAVEN |
HIC3 | W1Q |
HIC3 Description | QUINOLONE ANTIBIOTICS |
GCN | 52121 |
HICL Sequence Number | 006071 |
HICL Sequence Number Description | CIPROFLOXACIN LACTATE/DEXTROSE 5 % IN WATER |
Brand/Generic | Generic |
Proprietary Name | Ciprofloxacin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ciprofloxacin |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | CIPROFLOXACIN |
Labeler Name | Sagent Pharmaceuticals |
Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078252 |
Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0114-66 (25021011466)
NDC Package Code | 25021-114-66 |
---|---|
Billing NDC | 25021011466 |
Package | 24 POUCH in 1 CARTON (25021-114-66) / 1 BAG in 1 POUCH / 200 mL in 1 BAG |
Marketing Start Date | 2022-12-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |